Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00033540What this trial is testingS0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer SWOG Cancer Research Network 57
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT01313377What this trial is testingGemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer UNICANCER 190
Testing effectiveness (Phase 2)Study completedNCT00238212What this trial is testingS0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaWho this might be right forAdenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the Gallbladder+7 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT00010088What this trial is testingChemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile DuctWho this might be right forExtrahepatic Bile Duct CancerPancreatic Cancer GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00363584What this trial is testingCapecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer University Hospital Southampton NHS Foundation Trust 360
Testing effectiveness (Phase 2)Ended earlyNCT00478140What this trial is testingTrastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryWho this might be right forAdenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderMalignant Neoplasm+4 more National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT03044587What this trial is testingNal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerWho this might be right forAdenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more AIO-Studien-gGmbH 93